Dr. Shaikh is a Professor of Medicine whose research efforts focus on progression of endstage liver disease, treatment of hepatocellular carcinoma, hepatocarcinogenesis and genomic profiling of liver tumors, and allocation models for liver transplantation.
- MBBS, Dow Medical College, Karachi, Pakistan, 1979
- MRCP, Royal College of Physicians, London (UK), 1985
- Registrar, Medicine/Gastroenterology, Whiston Hospital - Prescot, UK, 1991
- Fellowship, Gastroenterology/Hepatology, University of Southern California - Los Angeles, 1993
- Clinical Associate, Hepatology, NIH - Bethesda, 1995
- Fellowship, Transplantation Medicine, University of Pittsburgh, 1996
Education & Training
Ragni, M.V., Moore, C.G., Soadwa, K., Nalesnik, M.A., Zajko, A.B., Cortese-Hassett, A., Whiteside, T.L., Hart, S., Zeevi, A., Li, J., Shaikh, O.S. Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia. Haemophilia. 2011; 17(1): 103-11.
Taylor, R.M., Tujios, S., Jinjuvadia, K., Davern, T., Shaikh, O.S., Han, S., Chung, R.T., Lee, W.M., Fontana, R.J. Short and long-term outcomes in patients with acute liver failure due to ischemic hepatitis. Digestive Diseases and Sciences. 2012; 57(3): 777-85.
Terrault, N., Reddy, R., Poordad, F., Curry, M., Schiano, T., Shaikh, O., Dove, L., Shetty, K., Millis, M., Schiff, E., Regenstein, F., Barnes, D., Barin, B., Peters, M., Roland, M. Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV-HIV Coinfected Liver Transplant Recipents. The American Journal of Transplantation. 2014; 14(5): 1129-35.
Rogal, S.S., Hu, A., Bandi, R., Shaikh, O. Novel therapy for non-cirrhotic hyperammonemia due to a spontaneous splenorenal shunt. World Journal of Gastroenterology. 2014; 20(25): 8288-91.
Butt, A.A., Yan, P., Bonilla, H., Abou-Samra, A.B., Shaikh, O.S., Simon, T.G., Chung, R.T., Rogal, S.S. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES. Hepatology. 2015; 62(2): 365-74.
Butt, A.A., Yan, P., Shaikh, O.S., Freiberg, M.S., Lo Re, V. 3rd, Justice, A.C., Sherman, K.E. Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings. The Journal of Viral Hepatitis. 2015; 22(9): 691-700.
Butt, A.A., Yan, P., Shaikh, O.S., Chung, R.T., Sherman, K.E. Sofosbuvir-based Regimens in Clinical Practice Achieve SVR Rates Closer to Clinical Trials. Liver International. 2015
Lau DTY, Ganov-Raeva L, Wang J, Mogul D, Chung RT, Lisker-Melman M, Chang KM, Shaikh OS, Janssen HLS, Wahed AS, Lok AS. Precore and Basal Core Promoter Hepatitis B (HBV) Variants are Present from a Young Age and Differ Across HBV Genotypes. Hepatology. 2020; Aug
Shaikh OS, Rogal S, Malik A, Sharma V, Cacciarelli T. Liver Transplant from Increased-risk Donors in the Era of Direct-acting Antivirals for Hepatitis C. Experimental Clinical Transplantation. 2019; July
- Royal College of Physicians, London, FRCP, 2003
- Transplant Workshop. Hot topics in organ allocation: roadway to a fairer system. AASLD annual meeting, Boston. Course co-director., 2009
